Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rochat

Showing results (181-190 of 233) with videos related to

Pageof 24
Sort By:
The Journal of Biological Chemistry|January 25, 1992
Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venomM Crest, G Jacquet, M Gola, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Structure-function relationships for cardiotoxins interacting with phospholipidsJ Dufourcq, J F Faucon, E Bernard, et al.
European Journal of Biochemistry|August 1, 1995
Recombinant and chemical derivatives of apamin. Implication of post-transcriptional C-terminal amidation of apamin in biological activityC Devaux, M Knibiehler, M L Defendini, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 26, 2015
[Comparative study of the outcome of surgical management of vesico-vaginal fistulas with and without interposition of the Martius graft: A Cameroonian experience]P-M Tebeu, J Fokom-Domgue, G Kengne Fosso, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanismsN Yahi, J Fantini, S Baghdiguian, et al.
General Pharmacology|October 29, 1998
Adenosine and the nervous system: pharmacological data and therapeutic perspectivesR Guieu, B Dussol, G Halimi, et al.
Vaccine|February 1, 1997
In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin III Zenouaki, R Kharrat, J M Sabatier, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 1, 1997
3D structure of kaliotoxin: is residue 34 a key for channel selectivity?M Gairí, R Romi, I Fernández, et al.
Life Sciences|January 6, 2000
Cyclosporine A and purinergic receptors in rat kidneyG Halimi, J Sampol, O Clot-Faybesse, et al.
Journal of Virology|September 1, 1994
Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophagesN Yahi, J Fantini, K Mabrouk, et al.
Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:
Pageof 24
The Journal of Biological Chemistry|January 25, 1992
Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venomM Crest, G Jacquet, M Gola, et al.
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Structure-function relationships for cardiotoxins interacting with phospholipidsJ Dufourcq, J F Faucon, E Bernard, et al.
European Journal of Biochemistry|August 1, 1995
Recombinant and chemical derivatives of apamin. Implication of post-transcriptional C-terminal amidation of apamin in biological activityC Devaux, M Knibiehler, M L Defendini, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 26, 2015
[Comparative study of the outcome of surgical management of vesico-vaginal fistulas with and without interposition of the Martius graft: A Cameroonian experience]P-M Tebeu, J Fokom-Domgue, G Kengne Fosso, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanismsN Yahi, J Fantini, S Baghdiguian, et al.
General Pharmacology|October 29, 1998
Adenosine and the nervous system: pharmacological data and therapeutic perspectivesR Guieu, B Dussol, G Halimi, et al.
Vaccine|February 1, 1997
In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin III Zenouaki, R Kharrat, J M Sabatier, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 1, 1997
3D structure of kaliotoxin: is residue 34 a key for channel selectivity?M Gairí, R Romi, I Fernández, et al.
Life Sciences|January 6, 2000
Cyclosporine A and purinergic receptors in rat kidneyG Halimi, J Sampol, O Clot-Faybesse, et al.
Journal of Virology|September 1, 1994
Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophagesN Yahi, J Fantini, K Mabrouk, et al.
Pageof 24